NIH funding by institute · Fiscal year 2026
National Institute of Allergy and Infectious Diseases (NIAID) Grants and Funding
Reviewed by Dr. Meng ZhaoLast reviewed October 26, 2026Data refreshed October 16, 2026Editorial standards
NIAID administered $4.27B in fiscal year 2026 across 6,142 award records to 260 institutions with $10M or more in NIH funding, down 4.3% from FY2025. Johns Hopkins University received the most, 4.1% of that total.
FY2026 closed on September 30, 2026, but NIH keeps posting that year's awards to RePORTER for several weeks. FY2026 figures reflect records available on October 16, 2026 and may rise slightly at the next refresh.
FY2026 NIAID funding
$4.27B
−4.3% vs FY2025
Award records
6,142
Institutions funded
260
Recipients with $10M+ in NIH funding
Open or upcoming NOFOs
77
NIAID as lead or participating institute
Top NIAID-funded institutions, FY2026
| # | Institution | NIAID FY2026 | vs FY2025 | Awards | Share |
|---|---|---|---|---|---|
| 1 | Johns Hopkins UniversityBaltimore, MD | $174.4M | +5.5% | 207 | 4.1% |
| 2 | University of California, San FranciscoSan Francisco, CA | $156.1M | +18.3% | 196 | 3.7% |
| 3 | Fred Hutchinson Cancer CenterSeattle, WA | $145.1M | −14.2% | 68 | 3.4% |
| 4 | Emory UniversityAtlanta, GA | $126.2M | −3.9% | 166 | 3.0% |
| 5 | Duke UniversityDurham, NC | $122.9M | −28.5% | 147 | 2.9% |
| 6 | University of North Carolina at Chapel HillChapel Hill, NC | $108.0M | +73.5% | 141 | 2.5% |
| 7 | University of PennsylvaniaPhiladelphia, PA | $89.2M | −1.4% | 109 | 2.1% |
| 8 | Washington University in St. LouisSaint Louis, MO | $87.9M | −10.0% | 156 | 2.1% |
| 9 | University of WashingtonSeattle, WA | $77.2M | +2.1% | 130 | 1.8% |
| 10 | University of PittsburghPittsburgh, PA | $76.6M | −1.4% | 136 | 1.8% |
| 11 | University of California, Los AngelesLos Angeles, CA | $74.7M | −33.8% | 92 | 1.7% |
| 12 | Columbia University Health SciencesNew York, NY | $74.4M | +43.9% | 106 | 1.7% |
| 13 | Weill Cornell MedicineNew York, NY | $70.2M | +1.8% | 87 | 1.6% |
| 14 | Scripps ResearchLa Jolla, CA | $68.3M | −0.7% | 56 | 1.6% |
| 15 | Massachusetts General HospitalBoston, MA | $65.5M | +0.4% | 104 | 1.5% |
| 16 | University of MinnesotaMinneapolis, MN | $65.1M | +26.7% | 89 | 1.5% |
| 17 | Yale UniversityNew Haven, CT | $62.8M | −13.8% | 121 | 1.5% |
| 18 | Icahn School of Medicine at Mount SinaiNew York, NY | $57.7M | −18.5% | 72 | 1.4% |
| 19 | Brigham and Women's HospitalBoston, MA | $57.1M | +4.1% | 70 | 1.3% |
| 20 | Stanford UniversityStanford, CA | $57.1M | +8.4% | 92 | 1.3% |
| 21 | Boston Children's HospitalBoston, MA | $56.3M | −4.1% | 74 | 1.3% |
| 22 | Northwestern UniversityChicago, IL | $54.2M | +12.7% | 86 | 1.3% |
| 23 | University of Alabama at BirminghamBirmingham, AL | $52.6M | +13.5% | 68 | 1.2% |
| 24 | Benaroya Research Institute at Virginia MasonSeattle, WA | $51.4M | +20.0% | 27 | 1.2% |
| 25 | University of Wisconsin-MadisonMadison, WI | $49.4M | +8.3% | 78 | 1.2% |
Showing the 25 largest of 260 institutions with NIAID funding.
Open and upcoming NIAID funding opportunities
NOFOs led by NIAID first, then those NIAID participates in, soonest due date first. Browse every NIH NOFO.
- Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Radiological/Nuclear or Chemical Threats (U01 Clinical Trial Not Allowed)
RFA-AI-27-014 · U01
Next due Nov 9, 2026
- Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional)
RFA-AI-27-018 · R61, R33
Next due Nov 10, 2026
- Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
RFA-AI-27-002 · UM1
Next due Nov 10, 2026
- Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)
RFA-AI-27-005 · UM1
Next due Nov 10, 2026
- NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)
PAR-27-082 · P01
Next due Jan 25, 2027
Next due Jan 25, 2027
- Immune Tolerance Network (UM1 Clinical Trial Required)
RFA-AI-28-005 · UM1 · opens soon
Next due Jan 29, 2027
- Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)
RFA-AI-28-012 · U54 · opens soon
Next due Jan 29, 2027
- NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)
PAR-27-064 · U01
Next due Feb 5, 2027
- Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)
RFA-AI-28-024 · R61, R33 · opens soon
Next due Feb 11, 2027
Next due Feb 12, 2027
- Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) (P30 Clinical Trial Not Allowed)
PAR-28-090 · P30 · opens soon
Next due May 25, 2027
- Centers for Structural Biology of HIV and Other Infectious Diseases (U54 Clinical Trial Not Allowed)
RFA-AI-28-031 · U54 · opens soon
Next due May 28, 2027
- Lasker Clinical Research Scholar's Program (Si2/R00 Clinical Trial Optional)
PAR-27-076 · SI2, R00 · led by NIH
Next due Nov 6, 2026
- Limited Competition: Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38 Clinical Trial Not Allowed)
RFA-HL-27-010 · K38 · led by NHLBI
Next due Nov 9, 2026
Showing 15 of 77. See all NIAID NOFOs.
Recent NIAID awards
The newest NIAID award notices among the institutions above, each linked to its NIH RePORTER record.
- Quantifying Pollen Allergens with DNA Metabarcoding (opens NIH RePORTER)
University of Washington · 1R01AI204107-01 · NIAID · Notice Sep 30, 2026
$379KR01
- Developing Integration and Modeling Frameworks for Single-Cell and Bulk Transcriptomics to Analyze Atlas-Scale Cell-Resolved Immune Variation Across Infections and Vaccinations (opens NIH RePORTER)
Yale University · 1R01AI198335-01A1 · NIAID · Notice Sep 29, 2026
$570KR01
- Severe Cutaneous Adverse Reaction (SCAR) Clinical Research Consortium (CRC) (opens NIH RePORTER)
Vanderbilt University Medical Center · 1U54AI205728-01 · NIAID · Notice Sep 22, 2026
$1.8MU54
- Testing the "Stigma Reduction Logic Model Plus" (SRLM+): A Structural Approach to Addressing HIV-related Stigma in Healthcare Settings (opens NIH RePORTER)
New York State Psychiatric Institute · 1R01AI207137-01 · NIAID · Notice Sep 22, 2026
$741KR01
- Connecting Mechanics and Molecules to Understand Cell and Tissue Invasion by Apicomplexan Parasites (opens NIH RePORTER)
University of California San Diego · 1DP2AI192730-01 · NIAID · Notice Sep 21, 2026
$480KDP2
- Center for Spillover Prevention, One Health Research, and Outbreak Readiness in Asia (SPORA) (opens NIH RePORTER)
Cornell University · 1U01AI190384-01 · NIAID · Notice Sep 18, 2026
$1.3MU01
- Latin American Center for Emerging Infectious Disease Research (LACER) (opens NIH RePORTER)
University of California, Davis · 1U01AI190394-01 · NIAID · Notice Sep 18, 2026
$952KU01
- Subtype C HIV-1 Reservoir in Pregnancy-specific Compartments (opens NIH RePORTER)
Weill Cornell Medicine · 1R01AI203452-01 · NIAID · Notice Sep 18, 2026
$898KR01
- Integrated Genomic and Immunoproteomic Strategy for Development of a Next-Generation Chagas Disease Diagnostic Assay (opens NIH RePORTER)
University of California, San Francisco · 1R01AI201572-01 · NIAID · Notice Sep 18, 2026
$770KR01
- A hybrid effectiveness-implementation trial of a urine point-of-care assay to increase PrEP adherence among women in Kenya (opens NIH RePORTER)
University of Washington · 1R01AI189297-01A1 · NIAID · Notice Sep 18, 2026
$709KR01
Looking for a postdoc in immunology and infectious disease?
See how many immunology and infectious disease labs received a new NIAID R01 or R00 in the last three months, by month, state, and institution.
Newly funded immunology and infectious disease labsQuestions about NIAID funding
- How much does NIAID fund?
- In fiscal year 2026, NIAID administered $4.27B across 6,142 award records to the 260 institutions on this page. These are the recipients with $10M or more in total NIH funding, so the figure is a large share of NIAID's extramural awards but not its full budget.
- Which institutions get the most NIAID funding?
- Johns Hopkins University ($174.4M), University of California, San Francisco ($156.1M), Fred Hutchinson Cancer Center ($145.1M) led NIAID funding in FY2026.
- How do I find an open NIAID funding opportunity?
- This page lists open and upcoming NOFOs where NIAID is the lead or a participating institute, with the next due date. Most investigator-initiated applications go through the NIH parent announcements instead, and are assigned to an institute after submission; contact a NIAID program officer before you apply to check fit.
More NIH funding rankings
By type
University and health systems
By NIH institute
All institutes · NCI · NIA · NHLBI · NIGMS · NINDS · NIDDK · NIMH · OD · NICHD · NIDA · NCATS · NEI · NIAMS · NIEHS · NHGRI · NIAAA · NIDCD · NIDCR · NIBIB · NIMHD · NCCIH · NINR · NLM · FIC
By state
California · New York · Massachusetts · Pennsylvania · Texas · North Carolina · Maryland · Illinois · Washington · Ohio · Michigan · Florida · Missouri · Connecticut · Georgia · Minnesota · Tennessee · Wisconsin · Virginia · Colorado · New Jersey · Indiana · Oregon · Arizona · Alabama · Utah · Rhode Island · South Carolina · Kentucky · District of Columbia · Louisiana · Iowa · Oklahoma · Kansas · Nebraska · New Hampshire · New Mexico · Maine · Arkansas · Delaware · Mississippi · Vermont · Hawaii · Montana · West Virginia · Puerto Rico · South Dakota · Nevada · Idaho · North Dakota · Alaska · Wyoming